@article{bbbe676271bc432b81143fd84ea5cd28,
title = "Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies",
keywords = "Beta-glucuronidase, Cancer, Fluorescent probe, Oncolytic virus, Reporter",
author = "Michael Hess and Jochen Stritzker and Barbara H{\"a}rtl and Sturm, {Julia B.} and Ivaylo Gentschev and Szalay, {Aladar A.}",
note = "Funding Information: We like to thank Q. Zhang, N. Chen, T. Trevino and J. Aguilar for providing all rVACV, A. Seidensal and J. Langbein for excellent technical assistance. This work was supported by Genelux Corporation (R&D facility in San Diego, CA, USA) and Genelux GmbH, a Service Grant to the University of W{\"u}rzburg, Germany also funded by Genelux Corp., San Diego, USA as well as a grant of the “Bundesministerium f{\"u}r Bildung und Forschung” in the MoBiTech initiative (grant number 13N4051). JS, BH, IG and AAS are employees and shareholders of Genelux Corporation and Genelux GmbH respectively. MH and JBS are supported by graduate stipends from Genelux Corporation, San Diego. Funding Information: The research was supported by the Research and Development Division of Genelux Corp., San Diego, USA, and a Service Grant to the University of Funding Information: W{\"u}rzburg, Germany also funded by Genelux Corp., San Diego, USA as well as a grant of the “Bundesministerium f{\"u}r Bildung und Forschung” in the MoBiTech initiative (grant number 13N4051). JS, BH, IG and AAS are employees and shareholders of Genelux Corporation and Genelux GmbH respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No competing interests exist for MH and JBS.",
year = "2011",
month = oct,
day = "11",
doi = "10.1186/1479-5876-9-172",
language = "English",
volume = "9",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
number = "1",
}